| Name: | Alfuzosin EP Impurity G |
| Catalogue No. | VL259010 |
| CAS No. | 928780-95-4 |
| Molecular Formula | C24H30N8O4 |
| Molecular Weight | 494.56 |
| Status | In-stock |
| IUPAC Name | N2-(3-(4-amino-6,7-dimethoxyquinazolin-2-ylamino)propyl)-6,7-dimethoxy-N2- methylquinazoline-2,4-dia |
| Appearance | Light Orange powder |
| Description | Alfuzosin EP Impurity G (cas no.-928780-95-4) IUPAC Name-N2-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)amino)propyl)-6,7-dimethoxy-N2-methylquinazoline-2,4-diamine . Alfuzocin EP Impurity G is an impurity of Alfuzocin. Alfuzosin is used in the treatment of benign prostatic hyperplasia. It's a quinazoline derivative, it antagonizes α1-adrenoceptor selectively and competitively leading to contraction of the prostatic, prostatic capsule, bladder base, and proximal urethral smooth muscle, thereby red |
| References | Wilde, Michelle I., et al. “Alfuzosin.” Drugs, vol. 45, no. 3, Mar. 1993, pp. 410–29, https://doi.org/10.2165/00003495-199345030-00008. |
